Douglas Borkowski, MD
General Practice · Haskell, NJNPI 1285769851
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 3 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Genentech USA, Inc.. That places this record below the midpoint for general practice clinicians in NJ, where the typical reported total is $230.
Across 3 payments — averaging $13.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$40
Across 5 payments — averaging $12,288 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- BD$43K
- Orasure Technologies Inc.$19K
What the payments were for
- Food & beverage$40100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 3 | $40 |
How this compares
$40 in reported general payments places this provider in the 15th percentile of 2,978 general practice providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 22 | $1,296 |
| Azithromycin | 187 | $766 |
| Cefdinir | 36 | $716 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 41 | $497 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $388 |
| Methylprednisolone | 44 | $322 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 29 | $221 |
| Mometasone Furoate | 16 | $218 |
| Cephalexin | 35 | $203 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 26 | $124 |
| Tobramycin | 14 | $85 |
| Ondansetron OdtOndansetron | 14 | $84 |
| Amoxicillin | 28 | $82 |
| Doxycycline Hyclate | 16 | $72 |
| Ciprofloxacin Hcl | 21 | $62 |
Paid to pharmacies, not to this prescriber.
Other general practice in Haskell
- Ryan LakeClark$914K
- Hua-Yu Steven LiaoLodi$816K
- Howard GlazerFort Lee$636K
- Jeffrey ChustckieSomerset$165K
- John MinichettiEnglewood$142K
- Narenderan RajanHackettstown$135K
- Cindy YeungPiscataway$111K
- Andrew SpectorHaworth$75K
- Paul GoodmanPennington$42K
- Steven RasnerBridgeton$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.